Loading provider…
Loading provider…
Gastroenterology Physician in New York, NY
NPI: 1043585227Primary Practice Location
NYU LANGONE HOSPITALS
150 55th St, Brooklyn, NY
Primary Employer
NYU Faculty Group Practice
nyulangone.org
HQ Phone
Get M.D., M.P.H Jordan's Phone Numberphone_androidMobile
Get M.D., M.P.H Jordan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Tufts University School Of Medicine
medicine.tufts.edu
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 46 |
| 2 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 18 | 19 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 14 | 21 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 13 | 13 |
Authors: Shirley Cohen-Mekelburg, Garrett Lawlor, Ellen Scherl, Dana Lukin, Manasi Agrawal, Keith Sultan, Ryan Ungaro
Journal: Aliment Pharmacol Ther
Publication Date: 2019-01-20
Authors: Bret Lashner, Taha Qazi, Amy Lightner, Stefan Holubar, Jean-Paul Achkar, Ravi Shah, Benjamin Click, Salam Bachour
Journal: J Crohns Colitis
Cancer in Inflammatory Bowel Disease.
Authors: Adam Faye, Ariela Holmer, Jordan Axelrad
Publication Date: 2022-09-24
Lead Sponsor: NYU Langone Health
Intervention / Treatment: DRUG: Ustekinumab
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: TAK-018, DRUG: TAK-018 Placebo
Lead Sponsor: Vedanta Biosciences, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: VE303